{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:15Z","timestamp":1772165655487,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Identifying risk factors for severe novel-coronavirus disease (COVID-19) is useful to ascertain which patients may benefit from advanced supportive care. The study offers a description of COVID-19 patients, admitted to a general ward for a non-critical clinical picture, with the aim to analyse the differences between those transferred to the intensive (ICU) and\/or sub-intensive care (SICU) units and those who were not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This observational retrospective study includes all COVID-19 patients admitted to the Infectious Diseases Unit. Clinical, laboratory, radiological and treatment data were collected. The primary outcome was a composite of need of transfer to the ICU and\/or SICU during the hospitalization. Patients who did not require to be transferred are defined as Group 1; patients who were transferred to the ICU and\/or SICU are defined as Group 2. Demographic, clinical characteristics and laboratory findings at the 1st, 3rd and last measurements were compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      303 were included. The median age was 62\u2009years. 69 patients (22.8%) met the primary outcome and were defined as Group 2. The overall fatality rate was 6.8%. Group 2 patients were predominantly male (76.8% vs. 55.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), had a higher fatality rate (14.5% vs. 3.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090,01), had more hypertension (72.4% vs. 44%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090,01) and diabetes (31.9% vs. 21%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) and were more likely to present dry cough (49.3% vs. 25.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Overall, chest X-ray at admission showed findings suggestive of pneumonia in 63.2%, and Group 2 were more likely to develop pathological findings during the hospitalization (72.7% vs. 17.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). At admission, Group 2 presented significantly higher neutrophil count, aspartate-transaminase and C-Reactive-Protein. At the 3rd measurement, Group 2 presented persistently higher neutrophil count, hepatic inflammation markers and C-Reactive-Protein. Group 1 presented a shorter duration from admission to negativization of follow-up swabs (20 vs. 35\u2009days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The presence of comorbidities and the persistent observation of abnormal laboratory findings should be regarded as predisposing factors for clinical worsening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05647-7","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T05:34:00Z","timestamp":1607492040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-2945","authenticated-orcid":false,"given":"Anna Maria","family":"Cattelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Di Meco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Trevenzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Frater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Villano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Gomiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Carretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lolita","family":"Sasset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"5647_CR1","unstructured":"WHO. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020. Accessed 10 June 2020."},{"key":"5647_CR2","unstructured":"Ministero Della Salute. Novel Coronavirus \u2013 Situation report. http:\/\/www.salute.gov.it\/portale\/nuovocoronavirus\/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5351&area=nuovoCoronavirus&menu=vuoto. Accessed 10 June 2020."},{"key":"5647_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S0140-6736(20)30690","volume":"395","author":"A Saglietto","year":"2020","unstructured":"Saglietto A, D\u2019Ascenzo F, Zoccai GB, De Ferrari GM. COVID-19 in Europe: the Italian lesson. Lancet. 2020;395:1110\u20131. https:\/\/doi.org\/10.1016\/S0140-6736(20)30690.","journal-title":"Lancet."},{"key":"5647_CR4","doi-asserted-by":"publisher","unstructured":"Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.4031.","DOI":"10.1001\/jama.2020.4031"},{"key":"5647_CR5","doi-asserted-by":"publisher","unstructured":"Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model based analysis. Lancet Infect Dis. 2020;0. https:\/\/doi.org\/10.1016\/S1473-3099(20)30243-7.","DOI":"10.1016\/S1473-3099(20)30243-7"},{"key":"5647_CR6","volume-title":"Clinical management of COVID-19: interim guidance","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Clinical management of COVID-19: interim guidance. 2020. https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19. Accessed 2 June 2020."},{"issue":"10","key":"5647_CR7","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00134-012-2627-8","volume":"38","author":"A Rhodes","year":"2012","unstructured":"Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38(10):1647\u201353. https:\/\/doi.org\/10.1007\/s00134-012-2627-8.","journal-title":"Intensive Care Med"},{"key":"5647_CR8","doi-asserted-by":"publisher","unstructured":"Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368. https:\/\/doi.org\/10.1136\/bmj.m1091.","DOI":"10.1136\/bmj.m1091"},{"key":"5647_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"N Engl J Med"},{"key":"5647_CR10","doi-asserted-by":"publisher","unstructured":"Bhargava A, Fukushima EA, Levine M, et al. Predictors for severe COVID-19 infection. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa674.","DOI":"10.1093\/cid\/ciaa674"},{"key":"5647_CR11","doi-asserted-by":"publisher","unstructured":"Buckner FS, McCulloch DJ, Atluri V, et al. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington [published online ahead of print, 2020 May 22]. Clin Infect Dis. 2020;ciaa632. https:\/\/doi.org\/10.1093\/cid\/ciaa632.","DOI":"10.1093\/cid\/ciaa632"},{"key":"5647_CR12","doi-asserted-by":"publisher","first-page":"m1966","DOI":"10.1136\/bmj.m1966","volume":"369","author":"CM Petrilli","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. Published 2020 May 22. https:\/\/doi.org\/10.1136\/bmj.m1966.","journal-title":"BMJ"},{"key":"5647_CR13","doi-asserted-by":"publisher","unstructured":"Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369. https:\/\/doi.org\/10.1136\/bmj.m1985.","DOI":"10.1136\/bmj.m1985"},{"key":"5647_CR14","doi-asserted-by":"publisher","unstructured":"Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region: case series. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2004500.","DOI":"10.1056\/NEJMoa2004500"},{"key":"5647_CR15","doi-asserted-by":"publisher","unstructured":"Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy JAMA Published online April 06, 2020. https:\/\/doi.org\/10.1001\/jama.2020.5394.","DOI":"10.1001\/jama.2020.5394"},{"key":"5647_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/23744235.2020.1759817","volume":"52","author":"W Hou","year":"2020","unstructured":"Hou W, Zhang W, Jin R, Liang L, Xu B, Hu Z. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infect Dis (Lond). 2020;52:498\u2013505. https:\/\/doi.org\/10.1080\/23744235.2020.1759817.","journal-title":"Infect Dis (Lond)"},{"key":"5647_CR17","doi-asserted-by":"publisher","unstructured":"DaweiWang MD, Bo Hu MD, Chang Hu MD, Fangfang Zhu MD, Xing Liu MD, Jing Zhang MD, BinbinWang MD, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.1585.","DOI":"10.1001\/jama.2020.1585"},{"key":"5647_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1164\/ajrccm.163.2.9906116","volume":"163","author":"S Mehta","year":"2001","unstructured":"Mehta S, Hill NS. Non-invasive Ventilation. Am J RespirCrit Care Med. 2001;163:540\u201377. https:\/\/doi.org\/10.1164\/ajrccm.163.2.9906116.","journal-title":"Am J RespirCrit Care Med"},{"key":"5647_CR19","doi-asserted-by":"publisher","unstructured":"Lavezzo E, Franchin E, Ciavarella C, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2488-1.","DOI":"10.1038\/s41586-020-2488-1"},{"key":"5647_CR20","volume-title":"Vademecum per la curadellepersone con malattia da COVID-19 Edizione 2.0","author":"SIMIT (Societ\u00e0Italiana di MalattieInfettive e Tropicali) SEZIONE REGIONE LOMBARDIA","year":"2020","unstructured":"SIMIT (Societ\u00e0Italiana di MalattieInfettive e Tropicali) SEZIONE REGIONE LOMBARDIA. Vademecum per la curadellepersone con malattia da COVID-19 Edizione 2.0, 2020. https:\/\/www.sicp.it\/aggiornamento\/linee-guida-bp-procedures\/2020\/04\/pandemia-covid-19-sars-cov-2-26. Accessed 1 June 2020."},{"key":"5647_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12016-017-8648-x","volume":"56","author":"S Jaillon","year":"2019","unstructured":"Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019;56:308\u201321. https:\/\/doi.org\/10.1007\/s12016-017-8648-x.","journal-title":"Clin Rev Allergy Immunol"},{"key":"5647_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"key":"5647_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475\u201381. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5.","journal-title":"Lancet Respir Med"},{"key":"5647_CR24","doi-asserted-by":"publisher","unstructured":"Pascarella G, Strumia A, Chiara Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020. https:\/\/doi.org\/10.1111\/joim.13091.","DOI":"10.1111\/joim.13091"},{"key":"5647_CR25","doi-asserted-by":"publisher","unstructured":"Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID- 19): relationship to duration of infection. Radiology. 2020;200463. https:\/\/doi.org\/10.1148\/radiol.2020200463.","DOI":"10.1148\/radiol.2020200463"},{"key":"5647_CR26","doi-asserted-by":"publisher","unstructured":"Yi Huang S, Liu Y, Zhang Y, ChuyunZheng Y, Zheng CZ, Min W, Ming Y, Mingjun H. A preliminary study on the ultrasonic manifestations of peripulmonary lesions of non- critical novel coronavirus pneumonia (COVID-19). Res Square. https:\/\/doi.org\/10.21203\/rs.2.24369\/v1.","DOI":"10.21203\/rs.2.24369\/v1"},{"issue":"5","key":"5647_CR27","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139. https:\/\/doi.org\/10.1172\/JCI137244.","journal-title":"J Clin Invest"},{"key":"5647_CR28","doi-asserted-by":"publisher","unstructured":"Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020; S0092-8674(20)30610\u20133. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015.","DOI":"10.1016\/j.cell.2020.05.015"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05647-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05647-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05647-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T05:34:57Z","timestamp":1607492097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05647-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5647"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05647-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-38908\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-38908\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-38908\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Institutional Review Board of the University of Padua. In agreement with Italian national regulation on retrospective observational studies that do not imply experimentation on the patients or deviation from the standard clinical practice, the need for patient\u2019s written informed consent was waived. All participants gave instead verbal informed consent to the treating physician with the presence of a witness. The expressed consent was reported on the patient\u2019s clinical file together with the agreement of the personal data handling, which is always obtained at the beginning of hospitalization. All analyses were carried out on anonymised data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"934"}}